Answers are grounded in this paper and cite their sources.
Prospective cohort study shows association of hematologic changes with symptom burden in breast cancer, indicating need for integrated monitoring.
Early breast cancer pharmacotherapy induces dynamic hematologic and inflammatory changes associated with patient-reported symptoms, supporting integrated monitoring to improve toxicity management.
No takes yet. Share an insight, caveat, or question.
Sutanto et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: